Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
RUFY1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TMEM254 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
FNIP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC19A1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AP2M1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC101928830 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
APEH - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM104B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NDUFB3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DVL2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TFDP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SRR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TNNT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FKBP4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CSTF2T - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BCS1L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CHAF1A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on